- Home
- AEE vs IQV Comparison
AEE vs IQV Comparison
Compare AEE & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEE
- IQV
- Stock Information
- Founded
- AEE 1901
- IQV 1982
- Country
- AEE United States
- IQV United States
- Employees
- AEE N/A
- IQV N/A
- Industry
- AEE Power Generation
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- AEE Utilities
- IQV Health Care
- Exchange
- AEE Nasdaq
- IQV Nasdaq
- Market Cap
- AEE 27.3B
- IQV 31.0B
- IPO Year
- AEE N/A
- IQV 2013
- Fundamental
- Price
- AEE $100.62
- IQV $187.76
- Analyst Decision
- AEE Buy
- IQV Strong Buy
- Analyst Count
- AEE 11
- IQV 19
- Target Price
- AEE $102.82
- IQV $229.37
- AVG Volume (30 Days)
- AEE 1.4M
- IQV 1.2M
- Earning Date
- AEE 11-05-2025
- IQV 10-30-2025
- Dividend Yield
- AEE 2.82%
- IQV N/A
- EPS Growth
- AEE 2.91
- IQV N/A
- EPS
- AEE 4.55
- IQV 6.92
- Revenue
- AEE $8,119,000,000.00
- IQV $15,700,000,000.00
- Revenue This Year
- AEE $15.13
- IQV $6.01
- Revenue Next Year
- AEE $6.13
- IQV $5.05
- P/E Ratio
- AEE $22.13
- IQV $27.11
- Revenue Growth
- AEE 17.75
- IQV 3.60
- 52 Week Low
- AEE $82.79
- IQV $134.65
- 52 Week High
- AEE $104.10
- IQV $249.54
- Technical
- Relative Strength Index (RSI)
- AEE 51.25
- IQV 53.87
- Support Level
- AEE $98.91
- IQV $177.82
- Resistance Level
- AEE $101.28
- IQV $192.13
- Average True Range (ATR)
- AEE 1.13
- IQV 4.48
- MACD
- AEE -0.21
- IQV -1.14
- Stochastic Oscillator
- AEE 38.00
- IQV 54.02
About AEE Ameren Corporation
Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas through the company's two main subsidiaries, Ameren Missouri and Ameren Illinois. It serves 2.5 million electricity customers and approximately 1 million natural gas customers accross its two service territories.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.